Assignee
MCCORD DARLENE E
US·10 granted patents·6 pending applications·19 citations·filing 2013–2025
Top patents by PatentIndex Score
16 records- 0191US8796315B2Methods for improved wound closure employing olivamine and human umbilical vein endothelial cellsMCCORD DARLENE E·Filed 2013·Granted Aug 5, 2014·11 cites·18 claims
- 0284US9662302B2Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibitionMCCORD DARLENE E·Filed 2015·Granted May 30, 2017·2 cites·9 claims
- 0383US2026061061A1NON-ACTIVATED, AMORPHOUS, pH NEUTRAL, TWO-PART BEDSIDE-READY CLAY DELIVERY SYSTEM THAT TREATS PATHOGEN INFECTIONS IN HUMANS AND ANIMALSMCCORD DARLENE E·Filed 2025·Application pending·0 cites
- 0480US12478681B2Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animalsMCCORD DARLENE E·Filed 2023·Granted Nov 25, 2025·0 cites·20 claims
- 0579US10231939B2Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibitionMCCORD DARLENE E·Filed 2017·Granted Mar 19, 2019·2 cites·7 claims
- 0678US9144555B2Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibitionMCCORD DARLENE E·Filed 2013·Granted Sep 29, 2015·1 cites·9 claims
- 0774US9532970B2Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibitionMCCORD DARLENE E·Filed 2015·Granted Jan 3, 2017·1 cites·4 claims
- 0874US9289401B2Nutritional supplementsMCCORD DARLENE E·Filed 2014·Granted Mar 22, 2016·2 cites·17 claims
- 0968US11638759B2Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animalsMCCORD DARLENE E·Filed 2020·Granted May 2, 2023·0 cites·16 claims
- 1067US9018237B2Methods for improved wound closure employing olivamine and endothelial cellsMCCORD DARLENE E·Filed 2014·Granted Apr 28, 2015·0 cites·18 claims
- 1167US2025114398A1Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereofMCCORD DARLENE E·Filed 2024·Application pending·0 cites
- 1263US2018338947A1Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibitionMCCORD DARLENE E·Filed 2018·Application pending·0 cites
- 1362US12213993B2Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereofMCCORD DARLENE E·Filed 2022·Granted Feb 4, 2025·0 cites·21 claims
- 1459US2017065549A1Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibitionMCCORD DARLENE E·Filed 2016·Application pending·0 cites
- 1558US2024358745A1Compositions and methods of dissolving biofilm to promote wound healingMCCORD DARLENE E·Filed 2024·Application pending·0 cites
- 1639US2016354411A1Olivamine-induced improvement in endothelial cells viability and functionMCCORD DARLENE E·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MCCORD DARLENE E files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →